Les Hopitaux De Chartres

Futó vizsgálatok

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Forrás

• Még nem toboroz

  Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab

  NCT07836283· 3. fázis· Forrás

• Még nem toboroz

  ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

  NCT07737964· 3. fázis· Forrás

• Még nem toboroz

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· 3. fázis· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

  NCT07843498· 3. fázis· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· Forrás

• Toboroz

  Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  NCT07770841· 3. fázis· Forrás

• Toboroz

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  NCT07564414· 3. fázis· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Forrás

• Toboroz

  Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

  NCT07164859· 3. fázis· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

  2024-516652-18-00· 3. fázis· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Forrás

• Toboroz

  Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department

  2023-504847-15-00· 3. fázis· Forrás

• Toboroz

  Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

  NCT06906549· 4. fázis· Forrás

• Toboroz

  Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

  NCT06918002· 3. fázis· Forrás

• Toboroz

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· 3. fázis· Forrás

• Toboroz

  Beta-blOckers discoNtinuation in patients presenting heart FaIlure with REcovered left ventricular ejection fraction

  2023-508798-94-00· 3. fázis· Forrás

• Toboroz

  Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

  NCT06561854· 3. fázis· Forrás

• Toboroz

  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  NCT06283966· 3. fázis· Forrás

• Fut, nem toboroz

  Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

  NCT05889221· 2. fázis· Forrás

• Toboroz

  Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

  NCT05476991· 3. fázis· Forrás

• Toboroz

  Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

  NCT05732727· 3. fázis· Forrás

• Fut, nem toboroz

  MInimal Residual Disease Adapted Strategy

  NCT04934475· 3. fázis· Forrás

• Fut, nem toboroz

  Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

  NCT04276155· 4. fázis· Forrás

• Fut, nem toboroz

  Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).

  NCT04751877· 3. fázis· Forrás

• Toboroz

  Short Treatment with Omalizumab for Severe Asthma

  NCT04763447· 4. fázis· Forrás

• Toboroz

  Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for FOLFIRINOX (GEMFOX)

  NCT04167007· 2/3. fázis· Forrás

• Fut, nem toboroz

  Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

  NCT03653273· 3. fázis· Forrás

• Fut, nem toboroz

  Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

  NCT03323476· 3. fázis· Forrás

• Lezárult

  IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

  NCT02967289· 3. fázis· Forrás

• Fut, nem toboroz

  Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

  NCT01805271· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Szívelégtelenség5 toboroz
• Elhízás4 toboroz
• Mielóma multiplex3 toboroz
• Koszorúér-betegség2 toboroz
• Magas vérnyomás2 toboroz
• Stroke (szélütés)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Asztma1 toboroz
• Hasnyálmirigyrák1 toboroz
• Krónikus vesebetegség1 toboroz
• Pikkelysömör1 toboroz
• Rheumatoid arthritis1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

  NCT06797869· 2. fázis· Forrás

• Lezárult

  Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)

  2022-501133-23-00· 2. fázis· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Forrás

• Lezárult

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· 3. fázis· Forrás

• Lezárult

  Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

  NCT03993912· 3. fázis· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Forrás